Activity of combination chemotherapy in brain metastases from breast and lung adenocarcinoma.
about
Plasma and cerebrospinal fluid pharmacokinetics of topotecan in a phase I trial of topotecan, tamoxifen, and carboplatin, in the treatment of recurrent or refractory brain or spinal cord tumors.Breast cancer brain metastases: a review of the literature and a current multidisciplinary management guideline.First-line chemotherapy with vinorelbine, gemcitabine, and carboplatin in the treatment of brain metastases from non-small-cell lung cancer: a phase II study.Protracted low dose of oral vinorelbine and temozolomide with whole-brain radiotherapy in the treatment for breast cancer patients with brain metastases.Systemic immunotoxin treatment inhibits formation of human breast cancer metastasis and tumor growth in nude rats.
P2860
Activity of combination chemotherapy in brain metastases from breast and lung adenocarcinoma.
description
1997 nî lūn-bûn
@nan
1997 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Activity of combination chemot ...... reast and lung adenocarcinoma.
@ast
Activity of combination chemot ...... reast and lung adenocarcinoma.
@en
type
label
Activity of combination chemot ...... reast and lung adenocarcinoma.
@ast
Activity of combination chemot ...... reast and lung adenocarcinoma.
@en
prefLabel
Activity of combination chemot ...... reast and lung adenocarcinoma.
@ast
Activity of combination chemot ...... reast and lung adenocarcinoma.
@en
P2093
P1476
Activity of combination chemot ...... breast and lung adenocarcinoma
@en
P2093
P304
P356
10.1097/00000421-199706000-00020
P577
1997-06-01T00:00:00Z